Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Evelo Biosciences Inc (NQ: EVLO )

0.2500 -0.0088 (-3.40%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 162,955
Open 0.2778
Bid (Size) 0.2500 (28)
Ask (Size) 0.2530 (401)
Prev. Close 0.2588
Today's Range 0.2353 - 0.2778
52wk Range 0.2588 - 4.360
Shares Outstanding 53,398,292
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
From Evelo Biosciences, Inc.
Via Globe NewsWire
Earnings Preview: Evelo Biosciences
 
Via Benzinga

Performance

YTD
-84.08%
-84.08%
1 Month
-69.66%
-69.66%
3 Month
-84.66%
-84.66%
6 Month
-88.10%
-88.10%
1 Year
-92.26%
-92.26%

More News

Read More
Evelo Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
From Evelo Biosciences, Inc.
Via Globe NewsWire
Evelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference
From Evelo Biosciences, Inc.
Via Globe NewsWire
Evelo Biosciences: Q2 Earnings Insights
Via Benzinga
Evelo Biosciences Reports that EDP2939, its First Oral Extracellular Vesicle Product Candidate, Commenced Dosing in a Phase 2 Psoriasis Trial
From Evelo Biosciences, Inc.
Via Globe NewsWire
Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Evelo Biosciences' Atopic Dermatitis Study Fails, Observes Unusually High Placebo Response Rates
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Evelo Biosciences Provides Clinical and Business Updates
From Evelo Biosciences, Inc.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Evelo Biosciences Announces $45 Million Loan Agreement with Horizon Technology Finance Corporation to Refinance Existing Debt
From Evelo Biosciences, Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
Via Benzinga
Evelo Biosciences Announces Publication of Scientific Basis for SINTAX Medicines in Frontiers in Immunology
From Evelo Biosciences, Inc.
Via Globe NewsWire
Evelo Biosciences Reports Third Quarter 2022 Financial Results and Business Highlights
From Evelo Biosciences, Inc.
Via Globe NewsWire
Evelo Biosciences to Present at the 2022 Jefferies London Healthcare Conference
From Evelo Biosciences, Inc.
Via Globe NewsWire
Earnings Preview For Evelo Biosciences
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday
Via Benzinga
U.S. Stocks Turn Higher; Athira Pharma Shares Plummet
Via Benzinga
91 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Insiders Buy More Than $41M Of 2 Penny Stocks
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.